Tactic Pharma Llc - Net Worth and Insider Trading
Tactic Pharma Llc Net Worth
The estimated net worth of Tactic Pharma Llc is at least $15 Million dollars as of 2024-11-13. Tactic Pharma Llc is the 10% Owner of Monopar Therapeutics Inc and owns about 855,588 shares of Monopar Therapeutics Inc (MNPR) stock worth over $15 Million. Details can be seen in Tactic Pharma Llc's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Tactic Pharma Llc has not made any transactions after 2021-02-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Tactic Pharma Llc
Tactic Pharma Llc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Tactic Pharma Llc owns 1 companies in total, including Monopar Therapeutics Inc (MNPR) .
Click here to see the complete history of Tactic Pharma Llc’s form 4 insider trades.
Insider Ownership Summary of Tactic Pharma Llc
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| MNPR | Monopar Therapeutics Inc | 2021-02-11 | 10 percent owner |
Tactic Pharma Llc Latest Holdings Summary
Tactic Pharma Llc currently owns a total of 1 stock. Tactic Pharma Llc owns 855,588 shares of Monopar Therapeutics Inc (MNPR) as of February 11, 2021, with a value of $15 Million.
Latest Holdings of Tactic Pharma Llc
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MNPR | Monopar Therapeutics Inc | 2021-02-11 | 855,588 | 17.66 | 15,109,684 |
Holding Weightings of Tactic Pharma Llc
Tactic Pharma Llc Form 4 Trading Tracker
According to the SEC Form 4 filings, Tactic Pharma Llc has made a total of 2 transactions in Monopar Therapeutics Inc (MNPR) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in Monopar Therapeutics Inc is the sale of 25,000 shares on February 11, 2021, which brought Tactic Pharma Llc around $2 Million.
Insider Trading History of Tactic Pharma Llc
- 1
Tactic Pharma Llc Trading Performance
Tactic Pharma Llc Ownership Network
Ownership Network List of Tactic Pharma Llc
Ownership Network Relation of Tactic Pharma Llc
Tactic Pharma Llc Owned Company Details
What does Monopar Therapeutics Inc do?
Who are the key executives at Monopar Therapeutics Inc?
Tactic Pharma Llc is the 10 percent owner of Monopar Therapeutics Inc. Other key executives at Monopar Therapeutics Inc include Chief Operating Officer Andrew Cittadine , Chief Financial Officer Kim R Tsuchimoto , and director & Chief Executive Officer Chandler Robinson .
Monopar Therapeutics Inc (MNPR) Insider Trades Summary
Over the past 18 months, Tactic Pharma Llc made no insider transaction in Monopar Therapeutics Inc (MNPR). Other recent insider transactions involving Monopar Therapeutics Inc (MNPR) include a net purchase of 128,508 shares made by Andrew Cittadine , and a net purchase of 1,550 shares made by Karthik Radhakrishnan .
In summary, during the past 3 months, insiders sold 0 shares of Monopar Therapeutics Inc (MNPR) in total and bought 1,550 shares, with a net purchase of 1,550 shares. During the past 18 months, 0 shares of Monopar Therapeutics Inc (MNPR) were sold and 27,252 shares were bought by its insiders, resulting in a net purchase of 27,252 shares.
Monopar Therapeutics Inc (MNPR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Monopar Therapeutics Inc Insider Transactions
Tactic Pharma Llc Mailing Address
Above is the net worth, insider trading, and ownership report for Tactic Pharma Llc. You might contact Tactic Pharma Llc via mailing address: C/o Skokie Blvd., Suite 350, Wilmette Il 60091.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
